Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Pharma
ADC touts early Zynlonta results in marginal zone lymphoma
ADC Therapeutics provided several updates Monday, including that it's raising $105 million through a sale of common shares and pre-funded warrants.
Eric Sagonowsky
May 6, 2024 4:19pm
EyePoint reports Duravyu trial fail, raising questions
May 6, 2024 10:55am
AZ clinches early Calquence win in untreated MCL
May 2, 2024 10:24am
Novartis touts trial win, nabs priority review for Fabhalta
Apr 15, 2024 4:22pm
BMS touts KRAS confirmatory trial win after Amgen's stumble
Mar 29, 2024 10:35am
BMS' Zeposia comes up short in Crohn's disease study
Mar 29, 2024 8:15am